22717 results about "Wax" patented technology

A medical device having a contact surface exposed repeatedly to bodily tissue is disclosed. The contact surface is coated with a silicone polymer and one or more non-silicone hydrophobic polymers. The preferred medical device is a surgical needle, and the preferred coating is a polydimethylsiloxane and polypropylene wax hydrocarbon mixture. The incorporation of the non-silicone hydrophobic polymer increases the durability of the coating on the device without sacrificing lubricity.

Described are controlled, time-release microparticulate active and bioactive compositions (including perfuming compositions) for targeted delivery to surfaces such as skin, hair and fabric and the environment proximate thereto, where the active and bioactive materials have a calculated log10P values of between 1 and 8 (P being the n-octanol-water partition coefficient). Such compositions include the active or bioactive material in single phase, solid solution in a wax or polymer matrix also having coated thereon and/or containing a compatible surfactant. Also described are processes and apparatus for preparing such compositions and processes for using same. Furthermore, certain component(s) of the aforementioned compositions in combination with one another are novel, and other components have novel uses in increasing fragrance substantivity, particularly in hair care preparations such as hair gels and shampoos.

Solid free form fabrication techniques can be utilized indirectly to manufacture substrates, dies, models, near-net shapes, shells, and wax-ups that are then used in the manufacture of dental articles. Digital light processing is the most preferred indirect method for the production of substrates. After the substrates are produced, various coating or deposition techniques such as gel casting, slip casting, slurry casting, pressure infiltration, dipping, colloidal spray deposition or electrophoretic deposition are used to manufacture the dental article.

Described are controlled, time-release microparticulate active and bioactive compositions (including perfuming compositions) for targeted delivery to services such as skin, hair and fabric and the environment proximate thereto, where the active and bioactive materials have a calculated log10P values of between 1 and 8 (P being the n-octanol-water partition coefficient). Such compositions include the active or bioactive material in single phase, solid solution in a wax or polymer matrix also having coated thereon and/or containing a compatible surfactant. Also described are processes and apparatus for preparing such compositions and processes for using same. Furthermore, certain component(s) of the aforementioned compositions in combination with one another are novel, and other components have novel uses in increasing fragrance substantivity.

A process for dewaxing waxy hydrocarbonaceous materials, such as hydrocarbon fuel and lubricating oil fractions to reduce their cloud and pour points comprises reacting the material with hydrogen in the presence of a dewaxing catalyst comprising at least one metal catalytic component and ferrierite in which at least a portion of its cation exchange positions are occupied by one or more trivalent rare earth metal cations. The rare earth ion exchanged ferrierite catalyst has good selectivity for lubricating oil production, particularly when dewaxing a Fischer-Tropsch wax hydroisomerate. Preferably at least 10% and more preferably at least 15% of the ferreirite cation exchange capacity is occupied by one or more trivalent rare earth metal cations.

An implantable medical device is disclosed. The device is fabricated at least in part from a biocompatible, biodegradable composition. The composition is composed of a biocompatible, biodegradable polymer and a biocompatible, biodegradable wax. The concentration of the wax at the surface of the device is greater than the concentration of the wax in the body of the implantable device. The increased concentration of wax at the device surface may be attained when the device is heated to a temperature greater than the melting point of the wax and the glass transition temperature of the polymer, but lower than melting point of the polymer.

A process for manufacturing a lubricating base oil by: a) performing Fischer-Tropsch synthesis on syngas to provide a product stream; b) isolating from said product stream a substantially paraffinic wax feed having less than about 30 ppm total nitrogen and sulfur, and less than about 1 wt % oxygen; c) dewaxing said feed by hydroisomerization dewaxing using a shape selective intermediate pore size molecular sieve comprising a noble metal hydrogenation component, wherein the hydroisomerization temperature is between about 600° F. (315° C.) and about 750° F. (399° C.), to produce an is dimerized oil; and d) hydrofinishing said isomerized oil to produce a lubricating base oil having specific desired properties.

A process for manufacturing a finished lubricant by: a) performing Fischer-Tropsch synthesis on syngas to provide a product stream; b) isolating from said product stream a substantially paraffinic wax feed having less than about 30 ppm total nitrogen and sulfur, and less than about 1 wt % oxygen; c) dewaxing said feed by hydroisomerization dewaxing using a shape selective intermediate pore size molecular sieve comprising a noble metal hydrogenation component, wherein the hydroisomerization temperature is between about 600° F. (315° C.) and about 750° F. (399° C.), to produce an isomerized oil; and d) hydrofinishing said isomerized oil, whereby a lubricating base oil is produced having specific desired properties; and e) blending the lubricating base oil with at least one lubricant additive.

A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.

The invention relates to a method for hydrotreating heavy oil, in particular to the method for hydrotreating heavy oil, which improves the quality of diesel oil. Heavy distillate oil and animal and vegetable oil are used as raw material oil; under the hydrotreatment condition, the raw material oil and hydrogen gas are mixed and pass through a hydrotreatment reaction region; hydrogen-rich gas which is obtained by separating oil generated by hydrotreatment is circulated and utilized; and liquid obtained by separation is distillated to prepare a diesel oil product and hydrogenated wax oil. Compared with the prior art, the method can effectively improve the material source of a wax oil hydrotreatment device, ensure the quality of the hydrogenated wax oil, substantially increase the quality ofthe hydrotreated diesel oil and improve the storage stability of the animal and vegetable oil as fuel oil.

The invention is an automated robotic system for the production and testing of formulations at a very high throughput. It is an integrated system of hardware and software capable of preparing and evaluating hundreds of emulsions per day. The system can formulate aqueous solutions (SL), oil in water emulsions (EW), suspo-emulsions (SE), micro capsule suspensions (CS), micro-emulsions (ME), and suspension concentrates (SC) at the 1 ml to 25 ml scale. The system can process emulsions rapidly in an automated way and enable very flexible formulation recipes to be introduced. The system allows chemists to generate experimental samples of varying recipe and method to be conducted in parallel with projected throughput of up to 1200 formulations processed and characterized per day. Materials and consumables can be distributed from storage storage systems to the work stations where dispensing of ingredients in various states can be performed, including solids, liquids, gels, pastes, suspensions and waxes. The emulsions formed can be characterized using methods including phase diagnosis, turbidity analysis, viscosity and particle sizing using automated test equipment. An integrated module can also perform Tank Mix Compatibility testing in high throughput mode. The modular system allows future processes and tests to be added, either to a station, or as a new station. The software capability includes tracking of processes from start to finish and the integration of analytical data with the as-designed and as-formulated experimental results.

The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or more physiologically acceptable auxiliary substances (B) and optionally a synthetic, semi-synthetic or natural wax (D), wherein the dosage form exhibits a resistance to crushing of at least 400 N and wherein under physiological conditions the release of the physiologically active substances (A) from the dosage form is at least partially delayed.

Disclosed is a method for smoothing the surface of an object built from a polymeric or wax material using a layered manufacturing rapid prototyping technique. After the object is built it is exposed to a vaporized solvent such as in a vaporizer for an exposure time sufficient to reflow the object surface. A solvent is chosen based on its ability to transiently soften the material which forms the object, and thereafter evaporate off the object. The object is removed from the solvent and allowed to dry, producing a smooth finished part.

A high VI and low pour point lubricant base stock is made by hydroisomerizing a high purity, waxy, paraffinic Fischer-Tropsch synthesized hydrocarbon fraction having an initial boiling point in the range of 650-750° F., followed by catalytically dewaxing the hydroisomerate using a dewaxing catalyst comprising a catalytic platinum component and an H-mordenite component. The hydrocarbon fraction is preferably synthesized by a slurry Fischer-Tropsch using a catalyst containing a catalytic cobalt component. This combination of the process, high purity, waxy paraffinic feed and the Pt/H-mordenite dewaxing catalyst, produce a relatively high yield of premium lubricant base stock.

Lubricant blends and finished gear oils comprising a lubricant base oil fraction derived from highly paraffinic wax, a petroleum derived base oil, and a pour point depressant are provided. The lubricant base oil fraction derived from highly paraffinic wax comprises less than 0.30 weight percent aromatics, greater than 5 weight percent molecules with cycloparaffinic functionality, and a ratio of weight percent of molecules with monocycloparaffinic functionality to weight percent of molecules with multicycloparaffinic functionality greater than 15. The petroleum derived base oils comprises greater than 90 weight percent saturates and less than 300 ppm sulfur and is preferably selected from the group consisting of a Group II base oil, a Group III base oil, and mixtures thereof. These lubricant blends have surprising low Brookfield viscosities at −40° C.

A process for treating a wood substrate with a water-based formulation containing a wax in order to confer water repellency to the substrate comprising the steps of:(a) placing the substrate in a treatment vessel and reducing the pressure in the vessel to remove air in the pores of the substrate;(b) contacting the substrate in the vessel, while reduced pressure is present in the vessel, with the formulation to allow the formulation to flow into said pores, said contacting being carried out at a temperature at or above that required to cause the wax to change into a molten state;(c) applying a positive pressure to the vessel to force the formulation into said pores; and(d) releasing the pressure in the vessel and removing the resultant wood substrate from the vessel.

The present invention relates to a composition including a wax and a therapeutically effective amount of tar for topical treatment of a tar-responsive dermatological disorder, the composition being in liquid or light gel form when at a temperature selected from room temperature and a temperature of skin of a mammal upon application of the composition to the skin of the mammal. The invention also relates to a method of treating a tar-responsive dermatological disorder by topically applying the composition to skin of a mammal, preferably a human, that is involved with the disorder.

Topical compositions having as the active ingredient a lipid, fatty acid ester, natural wax, sterol, or combinations thereof referred to herein as “lipophilic vehicle” or “LV” and methods of use, have been developed for the amelioration or prevention of pain or the sequelae of pain. The composition may be in the form of an ointment, cream, gel, lotion, spray, foam, paste, patch, suspension or dispersion. In the preferred embodiment, the formulation is a gel. The LV may contain a penetration enhancer, most preferably one with membrane disruptive properties. The formulation may be applied to or impregnated into a gauze, wrap, bandage, cotton-tipped stick, adhesive bandage strip, or other support wrap or medical bandage or wound cover. For example, the compositions may be are incorporated onto or into disposables such as hemorrhoid wipes, sponge, mouth guards, dental trays; needles or catheters; adult diapers; gloves, socks or wrist bands, for ease of application. The composition is applied topically to a site at or adjacent to a painful region. The composition is reapplied as necessary. Pain relief is typically obtained within minutes and lasts for periods of variable duration ranging from minutes to several hours and even, in some cases, days. The composition is variably effective to treat visceral, somatic and neuropathic pain both acute and chronic as well as muscle pain and stiffness and joint pain and stiffness.

An improved water resistant gypsum board is made by adding an aqueous wax emulsion containing a cationic surfactant to an aqueous slurry containing calcium sulfate and host particles at a slurry temperature which maintains calcium sulfate hemihydrate crystals. The wax emulsion is stable at the temperature of slurry which maintains the calcium sulfate hemihydrate. The slurry is then dewatered and rehydrated to form a gypsum board and dried at a temperature to melt the wax.

Process for producing detachable dirt- and water-repellent surface coatings on articles, wherein during the coating process, hydrophobic particles are applied to the surface of the articles, thus generating a surface structure with elevations on that surface of the articles that has dirt- and water-repellent properties, which comprises suspending the hydrophobic particles in a solution of a silicone wax in a highly volatile siloxane, and applying this suspension to at least one surface of an article, and then removing the highly volatile siloxane.

A pharmaceutical composition may include a granulate which may include at least one active pharmaceutical ingredient susceptible to abuse by an individual mixed with at least two materials, a first material that is substantially water insoluble and at least partially alcohol soluble and a second material that is substantially alcohol insoluble and at least partially water soluble, wherein the active pharmaceutical ingredient and the two materials are granulated in the presence of water and alcohol. The composition may also include a coating on the granulate exhibiting crush resistance which may have a material that is deposited on the granulate using an alcohol based solvent. The composition further comprises a second particle comprising a fat/wax. The present invention also includes a coated granulate, various dosage forms of the composition, as well as methods of production and tableting.

A sectionable cassette for use in a process for harvesting and handling tissue samples for biopsy analysis is disclosed. In the procedure, a tissue biopsy sample is placed on a tissue trapping and supporting material that can withstand tissue preparation procedures and which can be cut with a microtome. The tissue is immobilized on the material and the material and the tissue are held in the cassette and are subjected to a process for replacing tissue fluids with wax, and then the tissue and the supporting material are sliced for mounting on slides using a microtome. Harvesting devices and containers using the filter material are disclosed. An automated process is also disclosed. One embodiment has the tissue trapping and supporting material porous and another embodiment includes a tissue supporting material that is not easily microtomed.